Biocon Biologics
Ramesh Ganesan is an executive at Biocon Biologics, having joined the company in February 2023, following a role in quality assurance at Cipla from March 2021 to February 2023. Ramesh completed a Bachelor of Technology in Biotechnology at Periyar Maniammai Institute of Science & Technology between 2015 and 2019 and received schooling with a focus on biology at Chellammal Matriculation Higher Secondary School from March 2013 to April 2015.
This person is not in any teams
This person is not in any offices
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics